Evaluation on the Effects of a Brief Hope Intervention to the Symptoms in the Palliative Care Patients
A Brief Hope Intervention to Increase the Hope Level and to Improve the Physical and Mental Health of Patients Receiving Palliative Care: a Randomized Controlled Trial
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
Aims. This paper describes the study protocol of a manualized brief positive intervention (BHI). In addition, it reports the on the modification of a hope intervention based on the theoretical proposition - hope theory, and its feasibility when applying to palliative cancer and non-cancer patients. Background. Hope was found to account for therapeutic changes in clients with depressive symptoms or chronic pain. Nevertheless, little is known about the integration of such active ingredients to brief and low intensity psycho-therapeutic interventions to patients receiving palliative care were not adequately tested. Design. The study included two stages: (1) manual development, and (2) a single blinded randomized controlled trial. Methods. Participants will be randomly assigned in equal number into either the brief hope intervention or the controlled arm on completion of the baseline assessment. Participants of the intervention group will be receiving the four-week intervention, while those allocated to the control arm will be receiving the routine care and social chats. The intervention is a manualized program that consists of four sessions at weekly intervals (two face to face sessions and two telephone follow up in between). The core content is modified from an eight sessions hope therapy. Expert panel feedback and trial on targeted populations were completed. Four participants received the program to determine its acceptability prior to feasibility testing. The process and practical considerations were evaluated to allow refinement of the program and to ensure the quality of intervention. Outcome measures comprise of changes in state hope score and the depression scores measured respectively by State Hope Scale and Centre for Epidemiological Study Depression Scale. The secondary outcomes are the common signs and symptoms in cancer patients measured by The Condensed Memorial Symptom Assessment Scale. Data collection will be done prior to the intervention (baseline), immediately and one month after the intervention. Additional use of qualitative interview to explore their experiences in the intervention, including satisfaction with the intervention and the treatment fidelity will be conducted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2017
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2017
CompletedFirst Posted
Study publicly available on registry
January 16, 2017
CompletedStudy Start
First participant enrolled
March 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2018
CompletedJanuary 23, 2017
January 1, 2017
1.2 years
January 12, 2017
January 20, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
State Hope Scale (SHS)
The SHS is a self-report instrument consisting of 6 items (Snyder et al., 1996) used to assess the two ongoing hope indices related to the pathways and agency of hopeful thinking. For instance, 'I can think of many ways to reach my current goals'. It takes approximately 5 minutes to complete. It is rated on an 8-point scale with 1 = definitely false and 8 = definitely true.
4 weeks
Secondary Outcomes (1)
The Condensed Memorial Symptom Assessment Scale (CMSAS)
4 weeks
Other Outcomes (2)
Center for Epidemiological Studies Depression Scale (CES-D)
4 weeks
Healthcare Resource Utilization
3 months
Study Arms (2)
Intervention Group
EXPERIMENTALThis is a 4-week Brief Hope Intervention Four sessions in total: two face-to-face sessions (1-hour) and two telephone follow up sessions (30 mins) in between. Homework : A booklet is prepared for the participants for reviewing their planned goals and recording achieved targets.
Control Group
EXPERIMENTALStandard care: Clinic follow up and normal hospital care. Logistic call and social communication On completion of the 4-week standard care, the 4-session brief hope intervention will be offered
Interventions
The present Brief Hope Intervention (BHI) is a four-weeks individual intervention: Hope enhancement strategies included sharing and recalling past successes, hope-based goal mapping exercises, examining possible pathways to reach the targeted goals, hope visualization exercise and positive self-talk. Purpose: help participants to develop positive thoughts. The programme consists of four sessions: Two face-to-face sessions (1-hour) and two telephone follow up (30 mins) Homework: A booklet is prepared for the participants for reviewing their planned goals and recording achieved targets.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Clinically diagnosed to have cancer or patients receiving palliative care
- Willing to participate in face-to-face activities and telephone follow up
- Alert and oriented, able to sustain for approximately one hour of attention and interaction
- Communicable in Cantonese, able to read and write Chinese
- Could be reached by phone
You may not qualify if:
- Patients having one or above of the below conditions will be excluded from the study.
- Patients who have planned operation or further chemotherapy and/or radiotherapy within three months
- Patients who are unable to communicate in Cantonese
- Patient who has hearing deficit
- Patient who are disoriented, delirious or cognitively impaired
- Patients who have been or is receiving counseling or psychotherapy
- Patients who are clinically depressed diagnosed by medical doctors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Chan Kitty, PhD
The Hong Kong Polytechnic University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
January 12, 2017
First Posted
January 16, 2017
Study Start
March 1, 2017
Primary Completion
April 30, 2018
Study Completion
May 1, 2018
Last Updated
January 23, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will share
Publication of results in May 2018